Search Results - "Cheung, Wk"

Refine Results
  1. 1

    Id reaction and allergic contact dermatitis post-picosecond laser tattoo removal: A case report by Wong, Ian TY, Cheung, Larry WK

    Published in SAGE open medical case reports (01-11-2021)
    “…The novel picosecond lasers have emerged as a mainstay device in laser tattoo removal alongside Q-switch lasers, considered the gold standard in the field…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses by CHIEN, S.-C, ROGGE, M. C, GISCLON, L. G, CURTIN, C, WONG, F, NATARAJAN, J, WILLIAMS, R. R, FOWLER, C. L, CHEUNG, W. K, CHOW, A. T

    Published in Antimicrobial Agents and Chemotherapy (01-10-1997)
    “…Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  3. 3

    Minimally Invasive Plate Osteosynthesis for Proximal Humeral Fractures by Koljonen, Paul Aarne, Fang, Christian, Lau, Tak Wing, Leung, Frankie, Cheung, Nigel WK

    Published in Journal of orthopaedic surgery (Hong Kong) (01-08-2015)
    “…Purpose. To report the outcome after minimally invasive plate osteosynthesis (MIPO) through the deltoid-splitting approach for proximal humeral fractures…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects by Krzyzanski, Wojciech, Jusko, William J., Wacholtz, Mary C., Minton, Neil, Cheung, Wing K.

    “…A pharmacokinetic and pharmacodynamic (PK/PD) model for recombinant human erythropoietin (Epoetin alfa) in healthy subjects was developed to describe the time…”
    Get full text
    Journal Article
  6. 6

    Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin After Single and Multiple Doses in Healthy Volunteers by Ramakrishnan, Rohini, Cheung, Wing K., Wacholtz, Mary C., Minton, Neil, Jusko, William J.

    Published in Journal of clinical pharmacology (01-09-2004)
    “…This study describes a pharmacokinetic (PK) model to account for serum recombinant human erythropoietin (rHuEpo) concentrations in healthy volunteers following…”
    Get full text
    Journal Article
  7. 7

    Automatic generation of artistic chinese calligraphy by Songhua Xu, Lau, F.C.M., Cheung, W.K., Yunhe Pan

    Published in IEEE intelligent systems (01-05-2005)
    “…Chinese calligraphy is among the finest and most important of all Chinese art forms and an inseparable part of Chinese history. Its delicate aesthetic effects…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Comparative pharmacokinetics of coumarin anticoagulants L: Physiologic modeling of S-warfarin in rats and pharmacologic target-mediated warfarin disposition in man by Levy, Gerhard, Mager, Donald E, Cheung, Wing K, Jusko, William J

    Published in Journal of pharmaceutical sciences (01-05-2003)
    “…The anticoagulant warfarin exemplifies a type of drug that exhibits high affinity to pharmacologic target sites of limited capacity, resulting in unusual…”
    Get more information
    Journal Article
  10. 10

    Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous dose administration in cynomolgus monkeys by Ramakrishnan, Rohini, Cheung, Wing K, Farrell, Francis, Joffee, Linda, Jusko, William J

    “…The pharmacokinetics (PK) and pharmacodynamics (PD) of recombinant human erythropoietin (rHuEpo) were investigated in monkeys. A two-compartment model with…”
    Get more information
    Journal Article
  11. 11

    Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma by Kuo, Hsu-Ping, Ezell, Scott A, Schweighofer, Karl J, Cheung, Leo W K, Hsieh, Sidney, Apatira, Mutiah, Sirisawad, Mint, Eckert, Karl, Hsu, Ssucheng J, Chen, Chun-Te, Beaupre, Darrin M, Versele, Matthias, Chang, Betty Y

    Published in Molecular cancer therapeutics (01-07-2017)
    “…Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma are the most prevalent B-lymphocyte neoplasms in which abnormal activation of the Bruton tyrosine…”
    Get full text
    Journal Article
  12. 12

    Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects by Cheung, Wing K., Goon, Betty L., Guilfoyle, Mary C., Wacholtz, Mary C.

    Published in Clinical pharmacology and therapeutics (01-10-1998)
    “…Objectives To understand the pharmacokinetic and pharmacodynamic properties of recombinant human erythropoietin (epoetin alfa) and to continue to optimize…”
    Get full text
    Journal Article
  13. 13

    ON KNOWLEDGE GRID AND GRID INTELLIGENCE: A SURVEY by Cheung, William K., Liu, Jiming

    Published in Computational intelligence (01-05-2005)
    “…The next generation Web Intelligence (WI) aims at enabling users to go beyond the existing online information search and knowledge queries functionalities and…”
    Get full text
    Journal Article
  14. 14

    Food Store Intervention Trial Improves Caregiver Psychosocial Factors and Children’s Dietary Intake in Hawaii by Gittelsohn, Joel, Vijayadeva, Vinutha, Davison, Nicola, Ramirez, Vickie, Cheung, Leo W.K, Murphy, Suzanne, Novotny, Rachel

    Published in Obesity (Silver Spring, Md.) (01-02-2010)
    “…Diet-related chronic diseases are at epidemic levels in low-income ethnic minority populations. The purpose of this study is to decrease risk for obesity in…”
    Get full text
    Journal Article
  15. 15

    The Role of PIM1 in the Ibrutinib-Resistant ABC Subtype of Diffuse Large B-Cell Lymphoma by Kuo, Hsu-Ping, Hsieh, Sidney, Schweighofer, Karl J., Cheung, Leo WK, Wu, Shiquan, Apatira, Mutiah, Sirisawad, Mint, Eckert, Karl, Liang, Yu, Hsu, Jeff, Chang, Betty Y.

    Published in Blood (03-12-2015)
    “…Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL), accounting for roughly 30% of newly diagnosed…”
    Get full text
    Journal Article
  16. 16

    Mutation Impact of Targeted Genes in Diffuse Large B-Cell Lymphoma Patients Treated with Ibrutinib by Cheung, Leo WK, Schweighofer, Karl J., Wu, Shiquan, Kuo, Hsu-Ping, Eckert, Karl, Balasubramanian, Sriram, Ricci, Deborah, Liang, Yu, Beaupre, Darrin, Chang, Betty Y.

    Published in Blood (03-12-2015)
    “…Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma, accounting for approximately 30% of newly diagnosed…”
    Get full text
    Journal Article
  17. 17

    Protective roles of Cordyceps on lung fibrosis in cellular and rat models by Chen, Mengli, Cheung, Florence W.K., Chan, Ming Hung, Hui, Pak Kwan, Ip, Siu-Po, Ling, Yick Hin, Che, Chun-Tao, Liu, Wing Keung

    Published in Journal of ethnopharmacology (28-09-2012)
    “…Cordyceps sinensis is a fungus used in traditional Chinese medicine as a tonic to soothe the lung for the treatment of fatigue and respiratory diseases…”
    Get full text
    Journal Article
  18. 18

    Abstract 3072: Combination of ibrutinib and corticosteroids in B-cell non-Hodgkin lymphomas (NHL) by Kuo, Hsu-Ping, Hsieh, Sidney, Schweighofer, Karl J., Cheung, Leo WK, Apatira, Mutiah, Sirisawad, Mint, Wu, Shiquan, Eckert, Karl, Liang, Yu, Hsu, Jeff, Chen, Chun-Te, Beaupre, Darrin, Chang, Betty Y.

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Introduction: The B-cell receptor (BCR) signaling pathway is a major driver in the pathogenesis of B-cell malignancies. A vast array of BCR-associated kinases…”
    Get full text
    Journal Article
  19. 19

    The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma by Kuo, Hsu-Ping, Ezell, Scott A, Hsieh, Sidney, Schweighofer, Karl J, Cheung, Leo Wk, Wu, Shiquan, Apatira, Mutiah, Sirisawad, Mint, Eckert, Karl, Liang, Yu, Hsu, Jeff, Chen, Chun-Te, Beaupre, Darrin, Chang, Betty Y

    Published in American journal of cancer research (01-01-2016)
    “…Diffuse large B cell lymphoma (DLBCL) is a heterogeneous lymphoma and the most common subtype of non-Hodgkin lymphoma, accounting for roughly 30% of newly…”
    Get full text
    Journal Article
  20. 20

    Combination of Ibrutinib and BCL-2 or SYK Inhibitors in Ibrutinib Resistant ABC-Subtype of Diffuse Large B-Cell Lymphoma by Kuo, Hsu-Ping, Crowley, Richard, Xue, Ling, Schweighofer, Karl J., Cheung, Leo WK, Hsieh, Sidney, Eckert, Karl, Versele, Matthias, Chang, Betty Y.

    Published in Blood (06-12-2014)
    “…Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin’s lymphoma (NHL), accounting for roughly 30% of newly diagnosed…”
    Get full text
    Journal Article